Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of Results

17th Jul 2013 07:00

RNS Number : 4681J
PuriCore Plc
17 July 2013
 



PuriCore plc

("PuriCore" or the "Company")

17 July 2013

 

 

Notice of Results 

PuriCore (LSE: PURI), a global company focused on safely and effectively protecting people from the spread of infectious pathogens, will announce its interim results for the six months ended 30 June 2013, on Thursday 8 August 2013. PuriCore will also host a conference call and webcast for analysts and investors at 9:30am BST. To participate, please access the webcast through investor.puricore.com and use the conference call details below:

 

Conference Call Details

From the UK: +44 20 3139 4830

From the US: +1 718 873 9077

Pin code: 14528742#

 

A recording of the presentation will be archived on the Company's website at investor.puricore.com/events.

 

Enquiries

 

UK

US

FTI Consulting

Sage Strategic Marketing

Susan Stuart/Simon Conway

Jennifer Guinan

Victoria Foster Mitchell

+1 610 410 8111

+44 (0) 20 7831 3113

[email protected]

 

About PuriCore

PuriCore plc (LSE: PURI) is a global company focused on developing and commercialising proprietary solutions that protect people from the spread of infectious pathogens without causing harm to human health or the environment. PuriCore's antimicrobial technology and complementary products are used principally in well-established core businesses and emerging sectors of two broad markets: Health Sciences and Food & Agriculture. In the Health Sciences market, PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients in UK hospitals. PuriCore's breakthrough wound therapy solution is used to treat chronic and acute wounds including diabetic ulcers and burns as well as atopic dermatitis as dermatologic treatment products. In the Food & Agriculture market, PuriCore's product portfolio provides savings to supermarket retailers in labour costs and improvements in inventory loss of fresh produce and floral products and addresses cross-contamination. In addition, the Company is progressing in its research and development programmes at Oxford University on the use of its technology as an agricultural fungicide. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOREASXKFSSDEFF

Related Shares:

RLM.L
FTSE 100 Latest
Value8,811.04
Change9.75